NCT01128712View on ClinicalTrials.gov

Effect on Anxiety in Partial Epilepsy Patients Treated With Pregabalin

PHASE4TerminatedINTERVENTIONAL

Enrollment

4

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions

Epilepsy, Complex Partial

Interventions

DRUG

Pregabalin

150 mg /day

DRUG

Pregabalin

450 mg/day

Trial Locations (1)

07601

Northeast Regional Epilepsy Group, Hackensack

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

Northeast Regional Epilepsy Group

OTHER